Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium

Human Reproduction

Volumn 22, Issue 4, 2007, Pages 927-937

  Xu, Xiulong ^a   Ding, Jianchi ^b   Rao, Geetha ^a   Shen, Jikun ^c   Prinz, Richard A ^a   Rana, Nasir ^b   Dmowski, W Paul ^b,d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Institute for the Study and Treatment of Endometriosis   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

Endometrium; Estradiol; Heparan sulphate; Heparanase; Ovarian hyperstimulation syndrome

Indexed keywords

ESTRADIOL; HEPARAN SULFATE; HEPARANASE; LUCIFERASE; PI 88; PROTEOHEPARAN SULFATE; RECOMBINANT FOLLITROPIN; BETA GLUCURONIDASE;

ADULT; ARTICLE; BASEMENT MEMBRANE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MICROSCOPY, FLUORESCENCE; OVARIAN HYPERSTIMULATION SYNDROME;

EID: 34347219755     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del483     Document Type: Article

References (62)

1. Bjornstrom L and Sjoberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19,833-842.
2. Budev MM, Arroliga AC and Falcone T (2005) Ovarian hyperstimulation syndrome. Crit Care Med 33,S301-S306.
3. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B et al. (2006) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57,359-383.
4. Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I and Abramovitch R (2006) Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118,1609-1617.
5. Delbaere A, Smits G, Olatunbosun O, Pierson R, Vassart G and Costagliola S (2004) New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod 19,486-489.
6. Dempsey LA, Plummer TB, Coombes SL and Platt JL (2000) Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 10,467-475.
7. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB and Braun DP (2001) Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod 16,1802-1808.
8. Edovitsky E, Elkin M, Zcharia E, Peretz T and Vlodavsky I (2004) Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 96,1219-1230.
9. Edovitsky E, Lerner I, Zcharia E, Peretz T, Vlodavsky I and Elkin M (2006) Role of endothelial heparanase in delayed-type hypersensitivity. Blood 107,3609-3616.
10. Edwards DP (2005) Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67,335-376.
11. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I and Vlodavsky I (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J 15,1661-1663.
12. Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T, Vlodavsky I and Kleinman HK (2003) Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63,8821-8826.
13. Esko JD and Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108,169-173.
14. Eustice DC, Feldman PA, Colberg-Poley AM, Buckery RM and Neubauer RH (1991) A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 11,739-740, 742-733.
15. Fairbanks MB, Mildner AM, Leone JW, Cavey GS, Mathews WR, Drong RF, Slightom JL, Bienkowski MJ, Smith CW, Bannow CA and Heinrikson RL (1999) Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem 274,29587-29590.
16. Geva E and Jaffe RB (2000) Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74,429-438.
17. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I and Ilan N (2004a) Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279,23536-23541.
18. Gingis-Velitski S, Zetser A, Kaplan V, Ben-Zaken O, Cohen E, Levy-Adam F, Bashenko Y, Flugelman MY, Vlodavsky I and Ilan N (2004b) Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem 279,23536-23541.
19. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Schirrmacher V, Mitrani E and Vlodavsky I (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 99,10031-10036.
20. Goldshmidt O, Zcharia E, Cohen M, Aingor H, Cohen I, Nadav L, Katz BZ, Geiger B and Vlodavsky I (2003) Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J 17,1015-1025.
21. Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, Aviv A, Vlodavsky I and Yagel S (2002) Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 8,566-573.
22. Hulett M, Freeman C, Hamdorf B, Baker R, Harris M and Parish C (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nature Medicine 5,803-809.
23. Ihrcke NS, Parker W, Reissner KJ and Platt JL (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 175,255-267.
24. Iozzo RV (2001) Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108,165-167.
25. Jiang P, Kumar A, Parrillo JE, Dempsey LA, Platt JL, Prinz RA and Xu X (2002) Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem 277,8989-8998.
26. Kaiser UB (2003) The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 349,729-732.
27. Kizaki K, Nakano H, Takahashi T, Imai K and Hashizume K (2001) Expression of heparanase mRNA in bovine placenta during gestation. Reproduction 121,573-580.
28. Kizaki K, Yamada O, Nakano H, Takahashi T, Yamauchi N, Imai K and Hashizume K (2003) Cloning and localization of heparanase in bovine placenta. Placenta 24,424-430.
29. Kodama J, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A and Hiramatsu Y (2006) Heparanase expression in both normal endometrium and endometrial cancer. Int J Gynecol Cancer 16,1401-1406.
30. Lincoln DW, II, Phillips PG and Bove K (2003) Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model. Breast Cancer Res Treat 78,167-178.
31. Lu WC, Liu YN, Kang BB and Chen JH (2003) Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 22,919-923.
32. Marchetti D and Nicolson GL (2001) Human heparanase: a molecular determinant of brain metastasis. Adv Enzyme Regul 41,343-359.
33. Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA and Xu X (2005) Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54,2172-2178.
34. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA and Hulett MD (2003) Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem 278,50377-50385.
35. de Mestre AM, Rao S, Hornby JR, Soe-Htwe T, Khachigian LM and Hulett MD (2005) Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells. J Biol Chem 280,35136-35147.
36. Mikami S, Ohashi K, Katsube K, Nemoto T, Nakajima M and Okada Y (2004) Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas. Pathol Int 54,556-563.
37. Morris JE, Potter SW and Gaza-Bulseco G (1988) Estradiol-stimulated turnover of heparan sulfate proteoglycan in mouse uterine epithelium. J Biol Chem 263,4712-4718.
38. Negrini D, Tenstad O, Passi A and Wiig H (2006) Differential degradation of matrix proteoglycans and edema development in rabbit lung. Am J Physiol Lung Cell Mol Physiol 290,L470-477.
39. Noyes RW and Haman JO (1953) Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses. Fertil Steril 4,504-517.
40. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA et al. (2005) Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 24,6762-6765.
41. Okawa T, Naomoto Y, Nobuhisa T, Takaoka M, Motoki T, Shirakawa Y, Yamatsuji T, Inoue H, Ouchida M, Gunduz M et al. (2005) Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res 11,7995-8005.
42. Owen GI, Richer JK, Tung L, Takimoto G and Horwitz KB (1998) Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273,10696-10701.
43. Parish CR, Freeman C and Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471,M99-M108.
44. Perrimon N and Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404,725-728.
45. Potter SW and Morris JE (1992) Changes in histochemical distribution of cell surface heparan sulfate proteoglycan in mouse uterus during the estrous cycle and early pregnancy. Anat Rec 234,383-390.
46. Pratt MA, Satkunaratnam A and Novosad DM (1998) Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells. Mol Cell Biochem 189,119-125.
47. Quiros RM, Rao G, Plate J, Harris JE, Brunn GJ, Platt JL, Gattuso P, Prinz RA and Xu X (2006) Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer 106,532-540.
48. Revel A, Helman A, Koler M, Shushan A, Goldshmidt O, Zcharia E, Aingorn H and Vlodavsky I (2005) Heparanase improves mouse embryo implantation. Fertil Steril 83,580-586.
49. Russo LA, Calabro SP, Filler TA, Carey DJ and Gardner RM (2001) In vivo regulation of syndecan-3 expression in the rat uterus by 17 beta-estradiol. J Biol Chem 276,686-692.
50. Singh M, Setalo G Jr, Guan X, Frail DE and Toran-Allerand CD (2000) Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J Neurosci 20,1694-1700.
51. Stringer SE and Gallagher JT (1997) Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem 272,20508-20514.
52. Vlodavsky I and Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108,341-347.
53. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5,793-802.
54. Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, Peretz T and Friedmann Y (2002) Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12,121-129.
55. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li JP, Lindahl U and Vlodavsky I (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 18,252-263.
56. Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S, Sarid R, Naggi A, Casu B, Ilan N et al. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J 19,211-221.
57. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I and Ilan N (2003) Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63,7733-7741.
58. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I and Ilan N (2004) Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117,2249-2258.
59. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I and Ilan N (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66,1455-1463.
60. Zhang XL, Simmen FA, Michel FJ and Simmen RC (2001) Increased expression of the Zn-finger transcription factor BTEB1 in human endometrial cells is correlated with distinct cell phenotype, gene expression patterns, and proliferative responsiveness to serum and TGF-beta1. Mol Cell Endocrinol 181,81-96.
61. Zhang D, Zhang XL, Michel FJ, Blum JL, Simmen FA and Simmen RC (2002) Direct interaction of the Kruppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells. Endocrinology 143,62-73.
62. Zhang XL, Zhang D, Michel FJ, Blum JL, Simmen FA and Simmen RC (2003) Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem 278,21474-21482.